75.89
Schlusskurs vom Vortag:
$76.27
Offen:
$77.07
24-Stunden-Volumen:
2.75M
Relative Volume:
1.93
Marktkapitalisierung:
$13.14B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
9.2955
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
-0.32%
1M Leistung:
+8.76%
6M Leistung:
-11.00%
1J Leistung:
+4.63%
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SOLV
Solventum Corp
|
75.89 | 13.21B | 8.28B | 1.43B | -203.00M | 8.1642 |
|
ISRG
Intuitive Surgical Inc
|
418.55 | 154.64B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.24 | 40.71B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
66.35 | 33.02B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
35.84 | 30.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
206.10 | 30.17B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum to Participate in the 2026 Jefferies Healthcare Conference - PR Newswire
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Goldman Sachs Adjusts Price Target on Solventum to $67 From $66, Maintains Sell Rating - marketscreener.com
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the industrial giant - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum Corporation (SOLV) Stock Report: Is A 6.83% Upside Worth The Dive? - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off, earnings pressure and legal risks in focus - AD HOC NEWS
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation - simplywall.st
Solventum stock is recovering: What's going on? - MSN
3M Company stock (US88579Y1010): Q1 2026 earnings and Solventum spin-off reshape the industrial gian - AD HOC NEWS
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Shareholders Back Board, Pay and Auditor Choices - TipRanks
Solventum (NYSE: SOLV) shareholders approve directors, pay plan and PwC auditor - Stock Titan
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative? - simplywall.st
What Are Wall Street Analysts' Target Price for Solventum Stock? - Barchart.com
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) director Carlos Alban receives 3,300 restricted stock units - Stock Titan
Solventum Corp (SOLV) director receives 4,848 restricted stock units - Stock Titan
Solventum (SOLV) director Susan DeVore awarded 3,300 restricted stock units - Stock Titan
Solventum (SOLV) director receives 3,300 Restricted Stock Units as equity grant - Stock Titan
Director Glenn Eisenberg receives 3,300 Solventum (SOLV) restricted stock units - Stock Titan
Solventum (SOLV) director awarded 3,300 RSUs vesting in 2027 - Stock Titan
Solventum (SOLV) director Karen May receives grant of 3,300 RSUs - Stock Titan
Director at Solventum (NYSE: SOLV) receives 3,300 RSU equity grant - Stock Titan
Solventum Corp (SOLV) director receives grant of 3,300 RSUs vesting 2027 - Stock Titan
Solventum (SOLV) director awarded 3,300 restricted stock units vesting in 2027 - Stock Titan
Solventum (SOLV) director receives 3,300 RSU award vesting in 2027 - Stock Titan
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Solventum Corporation (SOLV) Stock Analysis: Exploring a 10.53% Upside in the Healthcare Sector - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the Dow veteran - AD HOC NEWS
Wedbush initiates coverage of Solventum (SOLV) with outperform recommendation - MSN
Solventum (NYSE: SOLV) CHRO settles RSUs with tax withholding, updates share stake - Stock Titan
Solventum (SOLV) CFO exercises RSUs and uses 4,404 shares for taxes - Stock Titan
Solventum (SOLV) supply chain chief exercises 3,960 RSUs, 1,678 shares withheld for tax - Stock Titan
Solventum (NYSE: SOLV) CAO vests RSUs; 728 shares withheld for taxes - Stock Titan
Solventum (SOLV) legal chief exercises 4,488 RSUs, with 1,952 shares for tax - Stock Titan
Solventum (SOLV) CEO exercises RSUs, uses 13,503 shares for tax withholding - Stock Titan
Solventum (SOLV) CIO exercises 4,422 RSUs, withholds 2,017 shares for taxes - Stock Titan
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the industrial conglomerate - AD HOC NEWS
3M (MMM) Spin-off Solventum Receives Outperform Rating from Wedb - GuruFocus
Solventum Seen Positioned for Meaningful Re-Rating Over Next 12 to 18 Months, Wedbush Says - marketscreener.com
Wedbush Initiates Solventum at Outperform With $94 Price Target - marketscreener.com
Wedbush initiates Solventum stock coverage at Outperform By Investing.com - Investing.com Australia
Wedbush initiates Solventum stock coverage at Outperform - Investing.com
Solventum’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Solventum’s Next Chapter May Hinge On Shedding Non-Core Units - Finimize
Solventum (SOLV) Surpasses Q4 Earnings and Revenue Estimates - Eastern Progress
Solventum Foundation Expands Children’s Oral Health Access - Dentistry Today
Solventum Stock Tumbles as Tariff Fears Mount - TipRanks
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Solventum Corp-Aktie (SOLV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McMillan Wayde D. | Chief Financial Officer |
May 13 '26 |
Option Exercise |
0.00 |
9,503 |
0 |
53,041 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '26 |
Option Exercise |
0.00 |
3,960 |
0 |
22,130 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '26 |
Option Exercise |
0.00 |
2,376 |
0 |
7,632 |
| Kirberger Marcela A. | Chief Legal Affairs Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,488 |
0 |
15,492 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '26 |
Option Exercise |
0.00 |
34,315 |
0 |
158,225 |
| Landucci Amy | Chief Information Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,422 |
0 |
41,905 |
| Wendell Amy McBride | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
10,422 |
| WEILAND JOHN H | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
| Mily Elizabeth | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
9,009 |
| Wilson Darryl L. | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):